Tamboli Capital Peer Comparison

BSE: 533170

₹323.20

₹19.15 (6.30%)

As on 05-Nov-2026IST

Market cap

₹324 Cr

Revenue (TTM)

₹82 Cr

P/E Ratio

30.5

P/B Ratio

2.6

Div. Yield

0.4 %

Edit

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Market cap (₹ Cr)	324	8,779	207	62	43
Revenue (₹ Cr)	82	22,882	434	71	181
Net Profit (₹ Cr)	10.62	422.61	17.44	-6.24	2.66
Net Margin (%)	12.59	1.84	3.90	2.15	1.42
RoE (%)	9.30	7.66	6.80	-115.30	2.82
Price to Earnings	30.48	20.77	11.88	--	20.72
Price-To-Book	2.60	1.44	0.80	25.34	0.51

Income Statement (₹ Cr)

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Operating Income	80.43	23,505.54	430.87	61.87	130.23
Other Income	2.75	157.27	11.60	1.50	3.13
Total Income	83.18	23,662.81	442.48	63.37	133.35
Interest Expense	0.56	871.74	12.97	0.79	11.88
PBT & Exceptional Items	14.04	847.92	11.08	2.28	-5.74
Operating Expenses	64.21	21,745.77	407.51	57.54	123.85
Exceptional Income/Expenses	-0.60	-58.78	11.95	0.09	--
Profit before Tax	13.44	789.14	11.08	-0.99	-5.74
Taxes	3.63	183.55	1.61	0.08	0.36
Profit after Tax	9.81	605.59	9.47	-1.06	-6.11
Minority Interest	--	--	--	--	27.41
Share of Associate	--	--	--	--	--
Consolidated Profit	9.81	605.59	9.47	-12.41	-1.56

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Shareholder's Funds	122.45	6,159.69	257.94	2.31	72.51
Minority Interest	--	--	--	--	27.41
Non-Current Liabilities	2.31	515.16	68.01	8.14	65.54
Current Liabilities	9.40	18,007.82	236.55	55.00	102.48
Total Liabilities	134.69	25,133.45	567.57	68.45	267.94

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Non-Current Assets	75.09	2,473.59	313.41	39.29	90.00
Current Assets	59.07	22,209.08	249.09	26.27	177.94
Total Assets	134.69	25,133.45	567.57	68.45	267.94
Contingent Liabilities	2.67	188.22	16.95	4.61	--

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Cash From Operating Activities	12.08	-414.12	14.25	0.66	-6.74
Cash Flow from Investing Activities	-10.09	-241.80	-8.24	-9.76	24.74
Cash from Financing Activities	-5.36	510.97	-3.75	9.44	-18.30
Net Cash Inflow / Outflow	-3.37	-144.95	2.26	0.34	-0.29

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
ROCE (%)	11.43	16.35	6.08	-0.48	3.19
ROE (%)	8.31	10.53	3.76	-12.57	-9.25
ROA (%)	7.52	2.61	1.74	-1.56	-2.44
EBIT Margin (%)	23.59	8.16	8.12	9.42	7.30
Net Margin (%)	11.79	2.56	2.14	-1.68	-4.58
Cash Profit Margin (%)	17.64	3.42	4.72	2.75	-2.10

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Revenue Growth (%)	16.72	7.59	-2.78	10.80	-21.66
EBIT Growth (%)	18.11	9.54	-3.51	33.58	-61.80
Net Profit Growth (%)	27.10	6.11	-64.58	-250.62	-158.60
EPS Growth (%)	27.10	6.11	-64.58	-2.64	-124.45
Book Value Growth (%)	7.79	15.19	5.20	-84.21	9.39

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Price / Earnings	13.36	22.49	18.22	0.00	0.00
Price / Book Value	1.07	2.21	0.67	21.65	0.86
Dividend Yield (%)	0.91	1.08	0.00	0.00	0.00
EV/EBITDA	6.00	9.50	9.09	15.18	21.23
Market Cap (₹ Cr)	131.05	13,619.11	172.48	49.91	64.93

	Tamboli Capital	KEC International	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Debt to Equity	0.02	0.83	0.58	16.97	1.99
Short term debt to equity ratio	0.03	0.68	0.41	14.97	0.97
Current Ratio	6.28	1.23	1.05	0.48	1.74
Quick Ratio	4.84	1.15	0.60	0.33	1.33
Interest Coverage	25.20	1.91	1.85	-0.25	0.52

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.